Charles River Laboratories International, Inc. (CRL)
USD 183.16
(-3.26%)
USD 183.16
(-3.26%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 8.19 Billion USD | 7.79% |
| 2022 | 7.6 Billion USD | 8.24% |
| 2021 | 7.02 Billion USD | 27.93% |
| 2020 | 5.49 Billion USD | 17.01% |
| 2019 | 4.69 Billion USD | 21.7% |
| 2018 | 3.85 Billion USD | 31.6% |
| 2017 | 2.92 Billion USD | 8.04% |
| 2016 | 2.71 Billion USD | 31.1% |
| 2015 | 2.06 Billion USD | 9.72% |
| 2014 | 1.88 Billion USD | 14.63% |
| 2013 | 1.64 Billion USD | 3.67% |
| 2012 | 1.58 Billion USD | 1.8% |
| 2011 | 1.55 Billion USD | -10.1% |
| 2010 | 1.73 Billion USD | -21.36% |
| 2009 | 2.2 Billion USD | 2.05% |
| 2008 | 2.15 Billion USD | -23.01% |
| 2007 | 2.8 Billion USD | 9.7% |
| 2006 | 2.55 Billion USD | 0.76% |
| 2005 | 2.53 Billion USD | -3.37% |
| 2004 | 2.62 Billion USD | 228.54% |
| 2003 | 799.55 Million USD | 14.0% |
| 2002 | 701.34 Million USD | 22.75% |
| 2001 | 571.36 Million USD | 39.15% |
| 2000 | 410.6 Million USD | 13.1% |
| 1999 | 363.05 Million USD | 54.98% |
| 1998 | 234.25 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 8.15 Billion USD | -0.52% |
| 2024 Q2 | 7.94 Billion USD | -2.51% |
| 2023 Q2 | 7.77 Billion USD | 0.95% |
| 2023 FY | 8.19 Billion USD | 7.79% |
| 2023 Q3 | 7.6 Billion USD | -2.13% |
| 2023 Q1 | 7.69 Billion USD | 1.27% |
| 2023 Q4 | 8.19 Billion USD | 7.73% |
| 2022 Q3 | 7.38 Billion USD | -1.95% |
| 2022 Q1 | 7.07 Billion USD | 0.72% |
| 2022 FY | 7.6 Billion USD | 8.24% |
| 2022 Q4 | 7.6 Billion USD | 2.98% |
| 2022 Q2 | 7.52 Billion USD | 6.42% |
| 2021 Q2 | 6.72 Billion USD | 15.69% |
| 2021 Q4 | 7.02 Billion USD | -0.48% |
| 2021 FY | 7.02 Billion USD | 27.93% |
| 2021 Q1 | 5.8 Billion USD | 5.79% |
| 2021 Q3 | 7.05 Billion USD | 5.03% |
| 2020 Q4 | 5.49 Billion USD | 5.32% |
| 2020 Q1 | 5.2 Billion USD | 10.85% |
| 2020 Q3 | 5.21 Billion USD | -0.53% |
| 2020 Q2 | 5.24 Billion USD | 0.75% |
| 2020 FY | 5.49 Billion USD | 17.01% |
| 2019 Q3 | 4.58 Billion USD | -0.93% |
| 2019 Q2 | 4.62 Billion USD | 17.8% |
| 2019 FY | 4.69 Billion USD | 21.7% |
| 2019 Q4 | 4.69 Billion USD | 2.41% |
| 2019 Q1 | 3.92 Billion USD | 1.84% |
| 2018 Q1 | 3 Billion USD | 2.43% |
| 2018 Q3 | 3.79 Billion USD | -1.79% |
| 2018 Q4 | 3.85 Billion USD | 1.56% |
| 2018 FY | 3.85 Billion USD | 31.6% |
| 2018 Q2 | 3.86 Billion USD | 28.82% |
| 2017 Q2 | 2.77 Billion USD | 2.84% |
| 2017 Q4 | 2.92 Billion USD | 2.23% |
| 2017 FY | 2.92 Billion USD | 8.04% |
| 2017 Q1 | 2.69 Billion USD | -0.54% |
| 2017 Q3 | 2.86 Billion USD | 3.33% |
| 2016 Q2 | 2.76 Billion USD | 31.34% |
| 2016 FY | 2.71 Billion USD | 31.1% |
| 2016 Q3 | 2.69 Billion USD | -2.63% |
| 2016 Q4 | 2.71 Billion USD | 0.8% |
| 2016 Q1 | 2.1 Billion USD | 1.7% |
| 2015 Q1 | 1.84 Billion USD | -2.01% |
| 2015 FY | 2.06 Billion USD | 9.72% |
| 2015 Q4 | 2.06 Billion USD | 1.75% |
| 2015 Q3 | 2.03 Billion USD | 7.79% |
| 2015 Q2 | 1.88 Billion USD | 2.09% |
| 2014 Q1 | 1.65 Billion USD | 0.43% |
| 2014 Q2 | 1.86 Billion USD | 12.82% |
| 2014 FY | 1.88 Billion USD | 14.63% |
| 2014 Q4 | 1.88 Billion USD | 2.32% |
| 2014 Q3 | 1.84 Billion USD | -1.13% |
| 2013 FY | 1.64 Billion USD | 3.67% |
| 2013 Q3 | 1.64 Billion USD | 1.37% |
| 2013 Q1 | 1.6 Billion USD | 1.1% |
| 2013 Q2 | 1.62 Billion USD | 1.11% |
| 2013 Q4 | 1.64 Billion USD | 0.05% |
| 2012 Q2 | 1.54 Billion USD | -0.6% |
| 2012 FY | 1.58 Billion USD | 1.8% |
| 2012 Q1 | 1.55 Billion USD | -0.19% |
| 2012 Q4 | 1.58 Billion USD | 1.19% |
| 2012 Q3 | 1.56 Billion USD | 1.39% |
| 2011 Q2 | 1.7 Billion USD | -2.25% |
| 2011 Q4 | 1.55 Billion USD | -1.71% |
| 2011 FY | 1.55 Billion USD | -10.1% |
| 2011 Q1 | 1.74 Billion USD | 0.65% |
| 2011 Q3 | 1.58 Billion USD | -7.04% |
| 2010 Q2 | 2.15 Billion USD | -1.38% |
| 2010 Q1 | 2.18 Billion USD | -0.78% |
| 2010 FY | 1.73 Billion USD | -21.36% |
| 2010 Q4 | 1.73 Billion USD | -16.68% |
| 2010 Q3 | 2.08 Billion USD | -3.54% |
| 2009 Q1 | 2.08 Billion USD | -3.35% |
| 2009 FY | 2.2 Billion USD | 2.05% |
| 2009 Q4 | 2.2 Billion USD | 0.57% |
| 2009 Q3 | 2.19 Billion USD | 1.76% |
| 2009 Q2 | 2.15 Billion USD | 3.16% |
| 2008 Q3 | 2.89 Billion USD | 0.2% |
| 2008 Q1 | 2.84 Billion USD | 1.4% |
| 2008 FY | 2.15 Billion USD | -23.01% |
| 2008 Q4 | 2.15 Billion USD | -25.44% |
| 2008 Q2 | 2.89 Billion USD | 1.63% |
| 2007 Q4 | 2.8 Billion USD | 2.55% |
| 2007 Q1 | 2.56 Billion USD | 0.42% |
| 2007 FY | 2.8 Billion USD | 9.7% |
| 2007 Q3 | 2.73 Billion USD | 2.69% |
| 2007 Q2 | 2.66 Billion USD | 3.73% |
| 2006 Q1 | 2.41 Billion USD | -5.03% |
| 2006 FY | 2.55 Billion USD | 0.76% |
| 2006 Q4 | 2.55 Billion USD | 2.17% |
| 2006 Q3 | 2.5 Billion USD | -4.35% |
| 2006 Q2 | 2.61 Billion USD | 8.57% |
| 2005 FY | 2.53 Billion USD | -3.37% |
| 2005 Q4 | 2.53 Billion USD | -1.98% |
| 2005 Q3 | 2.58 Billion USD | 1.62% |
| 2005 Q2 | 2.54 Billion USD | -3.01% |
| 2005 Q1 | 2.62 Billion USD | 0.01% |
| 2004 FY | 2.62 Billion USD | 228.54% |
| 2004 Q4 | 2.62 Billion USD | 189.6% |
| 2004 Q3 | 907.04 Million USD | 5.18% |
| 2004 Q2 | 862.38 Million USD | 4.43% |
| 2004 Q1 | 825.82 Million USD | 3.29% |
| 2003 Q3 | 765.15 Million USD | 3.81% |
| 2003 Q4 | 799.55 Million USD | 4.5% |
| 2003 FY | 799.55 Million USD | 14.0% |
| 2003 Q2 | 737.06 Million USD | 4.38% |
| 2003 Q1 | 706.14 Million USD | 0.68% |
| 2002 Q1 | 664.19 Million USD | 16.25% |
| 2002 FY | 701.34 Million USD | 22.75% |
| 2002 Q4 | 701.34 Million USD | 6.86% |
| 2002 Q3 | 656.3 Million USD | 4.2% |
| 2002 Q2 | 629.88 Million USD | -5.17% |
| 2001 Q1 | 555.38 Million USD | 35.26% |
| 2001 Q2 | 516.79 Million USD | -6.95% |
| 2001 FY | 571.36 Million USD | 39.15% |
| 2001 Q3 | 586.07 Million USD | 13.4% |
| 2001 Q4 | 571.36 Million USD | -2.51% |
| 2000 Q3 | 409.12 Million USD | 2.56% |
| 2000 Q1 | 401.6 Million USD | 0.0% |
| 2000 Q2 | 398.9 Million USD | -0.67% |
| 2000 Q4 | 410.6 Million USD | 0.36% |
| 2000 FY | 410.6 Million USD | 13.1% |
| 1999 FY | 363.05 Million USD | 54.98% |
| 1998 FY | 234.25 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Agilent Technologies, Inc. | 10.76 Billion USD | 23.86% |
| Quest Diagnostics Incorporated | 14.02 Billion USD | 41.556% |
| Danaher Corporation | 84.48 Billion USD | 90.3% |
| Enzo Biochem, Inc. | 85.76 Million USD | -9455.292% |
| IQVIA Holdings Inc. | 26.68 Billion USD | 69.285% |
| Laboratory Corporation of America Holdings | 16.72 Billion USD | 51.002% |
| Mettler-Toledo International Inc. | 3.35 Billion USD | -144.222% |
| Qiagen N.V. | 6.11 Billion USD | -34.011% |
| Revvity, Inc. | 13.56 Billion USD | 39.586% |
| Thermo Fisher Scientific Inc. | 98.72 Billion USD | 91.699% |
| Waters Corporation | 4.62 Billion USD | -77.118% |